Breaking News Instant updates and real-time market news.

FGEN

FibroGen

$33.40

-1.6 (-4.57%)

08:39
08/08/17
08/08
08:39
08/08/17
08:39

FibroGen price target raised to $65 from $48 at Citi

Citi analyst Joel Beatty raised his price target for FibroGen to $65 after the company's Phase 2 trial of Pamrevlumab in idiopathic pulmonary fibrosis met its primary endpoint. The monotherapy benefit appears comparable to the two approved IPF drugs, which is encouraging, Beatty tells investors in a research note. He increased his probability of success for Pamrevlumab in IPF to 65% from 20%. FibroGen continues to be the analyst's top pick.

FGEN FibroGen
$33.40

-1.6 (-4.57%)

07/11/17
JEFF
07/11/17
NO CHANGE
JEFF
Jefferies fundamentally positive on Biotechnology, lists top picks
Jefferies analyst Michael Yee rolled out coverage of 12 Biotechnology names in a 550 page research report. The analyst is "fundamentally positive" on the sector, believing investor interest in large-caps will pick up "as the road to repair slowly continues." He believes the smid-cap space is "becoming a good stock-pickers' market." Yee's top picks in Biotech space include Celgene (CELG), Vertex (VRTX), Spark Therapeutics (ONCE), Prothena (PRTA) and Intercept (ICPT). The analyst's best picks in the smid-cap space are Spark, Prothena, Intercept and FibroGen (FGEN).
07/21/17
GSCO
07/21/17
DOWNGRADE
GSCO
Neutral
FibroGen downgraded to Neutral from Buy at Goldman Sachs
Goldman analyst Terence Flynn downgraded FibroGen to Neutral from Buy on valuation saying shares have surpassed his $31 price target and made no change to estimates.
08/08/17
JEFF
08/08/17
NO CHANGE
Target $75
JEFF
Buy
FibroGen price target raised to $75 from $50 at Jefferies
Jefferies analyst Michael Yee raised his price target for FibroGen (FGEN) shares to $75 saying "significant value creation should occur now" after the company reported positive Phase II idiopathic pulmonary fibrosis lung data for FG-3019. The analyst believes the $5B market capitalization implied by his new price target could prove conservative. InterMune had comparable data and was acquired by Roche (RHHBY) for $8B, Yee tells investors in a research note. The analyst reiterates a Buy rating on FibroGen. The stock in premarket trading is up 59%, or $19.60, to $53.00.
08/08/17
STFL
08/08/17
NO CHANGE
STFL
FibroGen price target raised to $80 from $38 at Stifel
Stifel analyst Thmas Shrader raised his price target on FibroGen after the company announced statistically significant trial results for its Pamrevlumab drug in IPF. The analyst estimates that the drug has a 50% chance of succeeding in IPF. He raised his price target on the shares to $80 from $38 and keeps a Buy rating on the stock.

TODAY'S FREE FLY STORIES

LTS

Ladenburg Thalmann

$2.79

-0.01 (-0.36%)

11:06
09/18/18
09/18
11:06
09/18/18
11:06
Periodicals
Ladenburg Thalmann mentioned cautiously by Seeking Alpha contributor »

A contributor to Seeking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

USB

U.S. Bancorp

$54.15

0.01 (0.02%)

11:05
09/18/18
09/18
11:05
09/18/18
11:05
Hot Stocks
U.S. Bancorp announces 23% increase in quarterly dividend to 37c per share »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

TLRY

Tilray

$141.50

21.3 (17.72%)

, CRON

Cronos Group

$11.43

1.25 (12.28%)

11:04
09/18/18
09/18
11:04
09/18/18
11:04
Hot Stocks
Cannabis stocks in focus after Tilray gets DEA approval to import cannabis drug »

Shares of cannabis stocks…

TLRY

Tilray

$141.50

21.3 (17.72%)

CRON

Cronos Group

$11.43

1.25 (12.28%)

KO

Coca-Cola

$46.14

-0.18 (-0.39%)

ACBFF

Aurora Cannabis

$0.00

(0.00%)

CGC

Canopy Growth

$50.36

1.84 (3.79%)

CBIS

Cannabis Science

$0.00

(0.00%)

IIPR

Innovative Industrial Properties

$44.09

1.12 (2.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Oct

  • 28

    Oct

P

Pandora

$9.70

0.21 (2.21%)

, SPOT

Spotify

$178.02

3.37 (1.93%)

11:01
09/18/18
09/18
11:01
09/18/18
11:01
Hot Stocks
Appeals court upholds Copyright Royalty Board rate determination »

SoundExchange challenged…

P

Pandora

$9.70

0.21 (2.21%)

SPOT

Spotify

$178.02

3.37 (1.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EDU

New Oriental Education

$67.99

-0.81 (-1.18%)

11:00
09/18/18
09/18
11:00
09/18/18
11:00
Options
Far upside call buyer in New Oriental Education and Technology Group »

Far upside call buyer in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:00
09/18/18
09/18
11:00
09/18/18
11:00
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

10:55
09/18/18
09/18
10:55
09/18/18
10:55
Conference/Events
Morgan Stanley healthcare/pharma analysts hold analyst/industry conference call »

Pharmaceuticals Analyst…

WM

Waste Management

$92.35

0.22 (0.24%)

10:55
09/18/18
09/18
10:55
09/18/18
10:55
Conference/Events
Waste Management has conference call hosted by UBS »

UBS Technology Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

ATHN

Athenahealth

$134.93

-8.325 (-5.81%)

10:50
09/18/18
09/18
10:50
09/18/18
10:50
Periodicals
Kosman says 'not true' that Post was wrong on Athenahealth »

Josh Kosman, one of two…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETE

Energy Transfer Equity

$17.38

0.07 (0.40%)

10:50
09/18/18
09/18
10:50
09/18/18
10:50
Options
Heavy bullish call volume in Energy Transfer Equity »

Heavy bullish call volume…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$160.67

0.07 (0.04%)

10:46
09/18/18
09/18
10:46
09/18/18
10:46
Periodicals
Facebook named in job ad discrimination lawsuit, TechCrunch reports »

Facebook has been named…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 28

    Oct

DLTR

Dollar Tree

$84.87

-0.63 (-0.74%)

10:40
09/18/18
09/18
10:40
09/18/18
10:40
Options
Dollar Tree draws bullish option flow »

Dollar Tree draws bullish…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 10

    Oct

WMT

Walmart

$94.92

0.09 (0.09%)

, TGT

Target

$87.72

0.45 (0.52%)

10:30
09/18/18
09/18
10:30
09/18/18
10:30
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…

WMT

Walmart

$94.92

0.09 (0.09%)

TGT

Target

$87.72

0.45 (0.52%)

APA

Apache

$46.69

0.91 (1.99%)

SUPN

Supernus

$47.80

1.85 (4.03%)

RIG

Transocean

$11.93

0.335 (2.89%)

NE

Noble Corp.

$6.21

0.25 (4.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 20

    Sep

  • 24

    Sep

  • 26

    Sep

  • 01

    Oct

  • 28

    Oct

  • 15

    Nov

  • 27

    Nov

  • 03

    Mar

FTNT

Fortinet

$88.88

0.69 (0.78%)

, UAL

United Continental

$89.26

-0.89 (-0.99%)

10:30
09/18/18
09/18
10:30
09/18/18
10:30
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…

FTNT

Fortinet

$88.88

0.69 (0.78%)

UAL

United Continental

$89.26

-0.89 (-0.99%)

WK

Workiva

$33.15

-4.65 (-12.30%)

DISCA

Discovery

$31.60

-0.41 (-1.28%)

APA

Apache

$46.69

0.91 (1.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 19

    Sep

  • 20

    Sep

  • 20

    Sep

  • 21

    Sep

  • 24

    Sep

  • 10

    Oct

  • 11

    Oct

  • 16

    Oct

  • 06

    Dec

  • 10

    Dec

CTSH

Cognizant

$76.97

1.02 (1.34%)

, CASY

Casey's General Stores

$127.78

2.48 (1.98%)

10:30
09/18/18
09/18
10:30
09/18/18
10:30
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…

CTSH

Cognizant

$76.97

1.02 (1.34%)

CASY

Casey's General Stores

$127.78

2.48 (1.98%)

OXY

Occidental Petroleum

$79.88

2.26 (2.91%)

VALE

Vale

$13.63

0.275 (2.06%)

TRGP

Targa Resources

$56.50

1.85 (3.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 19

    Sep

  • 20

    Sep

  • 21

    Oct

  • 06

    Nov

  • 16

    Nov

PBR

Petrobras

$11.04

0.115 (1.05%)

10:30
09/18/18
09/18
10:30
09/18/18
10:30
Options
Second day of size option block in Petrobras »

Second day of size option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTNX

Nutanix

$49.53

3.1 (6.68%)

, GOOG

Alphabet

$1,163.16

6.78 (0.59%)

10:26
09/18/18
09/18
10:26
09/18/18
10:26
Hot Stocks
Nutanix rises after analysts call selloff 'excessive', 'overblown' »

Shares of cloud computing…

NTNX

Nutanix

$49.53

3.1 (6.68%)

GOOG

Alphabet

$1,163.16

6.78 (0.59%)

GOOGL

Alphabet Class A

$1,166.89

7.56 (0.65%)

MSFT

Microsoft

$113.20

1.01 (0.90%)

VMW

VMware

$158.30

1.3 (0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 20

    Sep

  • 20

    Sep

  • 10

    Oct

  • 11

    Oct

  • 16

    Oct

  • 21

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 06

    Dec

  • 10

    Dec

  • 03

    Mar

10:25
09/18/18
09/18
10:25
09/18/18
10:25
Conference/Events
Leerink healthcare analysts to hold an analyst/industry conference call »

Healthcare Analysts…

JAZZ

Jazz Pharmaceuticals

$160.31

-0.66 (-0.41%)

10:25
09/18/18
09/18
10:25
09/18/18
10:25
Conference/Events
Jazz Pharmaceuticals to hold an informational webcast »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 27

    Oct

  • 27

    Nov

  • 20

    Dec

BWA

BorgWarner

$42.29

-1.87 (-4.23%)

10:25
09/18/18
09/18
10:25
09/18/18
10:25
Conference/Events
BorgWarner to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 25

    Oct

10:25
09/18/18
09/18
10:25
09/18/18
10:25
Conference/Events
Citigroup Healthcare IT analysts to an hold analyst/industry conference call »

Healthcare IT Analysts…

ATHN

Athenahealth

$134.10

-9.155 (-6.39%)

10:22
09/18/18
09/18
10:22
09/18/18
10:22
Hot Stocks
Athenahealth drops after Elliott said to pull back from $160 per share bid »

Shares of Athenahealth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIT

Fitbit

$5.73

0.28 (5.14%)

10:20
09/18/18
09/18
10:20
09/18/18
10:20
Options
Flurry of activity in FitBit calls as shares see strength »

Flurry of activity in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$94.85

0.02 (0.02%)

10:17
09/18/18
09/18
10:17
09/18/18
10:17
Periodicals
Bonobos co-founder and CEO Andy Dunn steps down, Inc reports »

Bonobos's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 15

    Nov

  • 03

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
09/18/18
09/18
10:17
09/18/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.